‘Unprecedented’ innovation comes at a price – Sanofi CEO
Heavyweights of the healthcare sector have been discussing innovation and who should pay for it at the Biovision meeting in Lyon, France.
Read MoreAuthor: Kevin Grogan
FDA approves Biogen haemophilia A therapy Eloctate
Biogen Idec been boosted by approval in the USA for its haemophilia A treatment Eloctate.
Read MoreGSK launches huge Phase III trial for heart drug losmapimod
GlaxoSmithKline has begun a Phase III study cardiovascular outcomes study of its investigational compound losmapimod in patients with acute coronary syndrome.
Read MoreGW Pharma’s Epidiolex on fast track in USA
GW Pharmaceuticals has been boosted by the news that the US Food and Drug Administration has granted fast-track designation to the UK firm’s investigational cannabidiol Epidiolex, in the treatment of Dravet syndrome.
Read MoreEFPIA’s ‘groundbreaking vision’ for life sciences in Europe
The European Federation of Pharmaceutical Industries and Associations has launched what it describes as “a landmark paper” outlining the steps it believes are needed for an integrated strategy for the life sciences sector in Europe.
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
